AVADEL PHARMACEUTICALS PLC

$AVDL
Institutional coverage

1 13F filers hold $AVDL.

13F holders
1
Insider buys · 90d
0
Congress · 90d
0

Smart Money · top-200 alpha cohort

No exposure this quarter

No top-200 alpha managers currently hold $AVDL. The institutional holders table below shows the broader 13F picture.

Institutional holders

Top 1 of 1 · Source: 13F-HR
01
Vanguard Group Inc.
5,864,781 sh

Insider activity · last 90 days

50 transactions · 8 filers
13 Feb 2026
Weiss Asset Management LP
▼ SOLD
11,112,052
$21.00
S
12 Feb 2026
Palczuk Linda
· D
11,000
D
12 Feb 2026
Palczuk Linda
· D
25,000
D
12 Feb 2026
Palczuk Linda
· D
11,000
D
12 Feb 2026
Palczuk Linda
· D
33,000
D
12 Feb 2026
Palczuk Linda
· D
42,000
D
12 Feb 2026
Palczuk Linda
· D
42,000
D
12 Feb 2026
Palczuk Linda
· D
42,000
D
12 Feb 2026
Palczuk Linda
· D
60,000
D
12 Feb 2026
Palczuk Linda
· D
78,905
$21.00
D
12 Feb 2026
Mchugh Thomas S
· D
72,000
D
12 Feb 2026
Mchugh Thomas S
· D
157,500
D

Transaction codes: P open-market purchase · S sale · M option exercise · A grant · F tax-withhold sale. Insider names link to each individual's expert page.

Congress trades · last 90 days

No Congress trades

No STOCK Act filings reference $AVDL in the recent window.

Convergence · $AVDL

active pattern signal
Pattern 04 · Hedge reversal
AVDL
AVADEL PHARMACEUTICALS PLC 7 of top-10 funds exited · held through 2025-12-31 · exit Q 2026-03-31

Pattern cards reflect public SEC EDGAR and Congressional filing data only. Detection uses filing dates; trade execution dates may differ. Past convergence patterns do not predict future returns. Nothing here is investment advice.

Source data: SEC EDGAR · 13F-HR · Form 4 · U.S. House Clerk PTR (disclosures-clerk.house.gov) · Senate eFD (senate.gov) · Last refreshed 12:16 UTC.